Lansoprazole and Erleada drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lansoprazole (lansoprazole) and Erleada (apalutamide). Common drug interactions include rash among males.

The phase IV clinical study analyzes what interactions people have when they take Lansoprazole and Erleada. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Lansoprazole?

Lansoprazole has active ingredients of lansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 129,663 Lansoprazole users. Check the latest studies of Lansoprazole.

What is Erleada?

Erleada has active ingredients of apalutamide. eHealthMe is studying from 7,519 Erleada users. Check the latest studies of Erleada.

On Jul, 08, 2026

35 people who take Lansoprazole and Erleada together, and have interactions are studied.

Lansoprazole and Erleada drug interactions.

What are the common drug interactions of Lansoprazole and Erleada, by gender? *:

female:

n/a

male:

Rash
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Pneumonia bacterial (pneumonia associated with bacterial infection)
Prerenal failure
Pyrexia (fever)
Respiratory failure (inadequate gas exchange by the respiratory system)
Decreased appetite
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Drug eruption (adverse drug reaction of the skin)

What are the common drug interactions of Lansoprazole and Erleada, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Hot flush (sudden feelings of heat)
Arthralgia (joint pain)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Herpes zoster
Respiratory tract infection viral

60+:

Rash
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Prerenal failure
Pyrexia (fever)
Respiratory failure (inadequate gas exchange by the respiratory system)
Decreased appetite
Drug eruption (adverse drug reaction of the skin)
Eosinophil count increased
Erythema multiforme (a type of hypersensitivity reaction)
Asthenia (weakness)

What are the existing conditions these people have? *

Prostate Cancer: 22 people, 62.86%
High Blood Pressure: 5 people, 14.29%
Enlarged Prostate: 5 people, 14.29%
Dyslipidaemia (abnormal amount of lipids): 4 people, 11.43%
Peripheral Swelling: 3 people, 8.57%
Spinal Ligament Ossification (spinal ligament changes into bony substance /hardening): 2 people, 5.71%
Seasonal Allergy (allergic condition due to certain season): 2 people, 5.71%
Prostate Cancer Metastatic: 2 people, 5.71%
Osteoporosis (bones weak and more likely to break): 2 people, 5.71%
Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Lansoprazole and Erleada?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously